TMC PULSE

t m c » p u l s e | d e c 2 0 1 7 /ja n 2 0 1 8 45 What Do Your Keystrokes Say About Parkinson's? Analyzing typing patterns may help diagnose the disease B y C h r i s t i n e H a l l Solutions: TMC Innovations stimulator—similar to a pacemaker— that sends electrical impulses to elec- trodes implanted in the brain. After this treatment, she said, researchers would be able to show improvement in some tasks and neuroplasticity. "This is on the verge of becoming a very important investigative tool and biomarker," Schiess said. B y the time Parkinson's disease is diagnosed, the damage is likely already done. But what if there was a way to check for early signs of this progressive dis- order of the nervous system? What if a smartphone app or computer keyboard could pick up Parkinson's just from the way someone swiped or typed? What if it could determine how well people with Parkinson's are responding to their medications? Using a combination of digital health applications and artificial intel- ligence (AI), Luca Giancardo, Ph.D., and other scientists in the Center for Precision Health at The University of Texas Health Science Center at Houston (UTHealth) have created a program that can isolate differences in the typing signatures of people with and without Parkinson's disease. As the population ages, the number of people diagnosed with the disorder is expected to rise. Warning signs of Parkinson's include rigidity or resting tremors, but with earlier inter- vention, doctors may be able to slow these symptoms. Yet Giancardo, an assistant profes- sor at UTHealth, said it's not practi- cal to test everyone for the onset of Parkinson's, even if there was an easy way to do it. Rather, it is better to moni- tor an activity people are already doing regularly to see if there are any clues that could lead to a possible diagnosis of the disorder. With that in mind, he developed a program that analyzes typing signatures—the keystroke patterns and quirks of individual users. The program can be downloaded onto a computer or smartphone and runs in the back- ground while users go about their day, using their computers and smart- phones as they normally would. Giancardo calls this type of moni- toring "passive monitoring," to denote a test that doesn't require any kind of special activity and can be done outside of the clinic. The goal, he said, is to find hidden patterns in the movements. The average person takes 100 milliseconds to press and release a key, he said. Whenever a person types on a smartphone or desktop computer, the pressure and speed of the move- ments will generate a score that would quantify the patterns in the typing signatures. "The measurements include the time from when you press a key until the time you release it," he added. At the moment, Giancardo is testing the program to see how people with Parkinson's disease are responding to their medications. Although the program is still in the research phase, results suggest that changes in the typing signature could indicate that a medication is not working. "We've learned from some animal studies that if we could diagnose people seven to 15 years earlier, we could get them using drugs designed to slow the neuron degeneration," Giancardo said. Giancardo hopes one day to extend these AI techniques to other conditions, including Alzheimer's, and to integrate them with imaging and other tools. Mya Schiess, M.D., has been work- ing with Giancardo for the past year and said this technology could be used to measure the mobility of individuals afflicted by Parkinson's. "We could profile their mobility and, once we get their measurement, show change over time or rate a disease that is progressive," said Schiess, vice chair of neurology and the Adriana Blood Endowed Chair in Neurology at McGovern Medical School at UTHealth, and a member of the medical staff at Memorial Hermann- Texas Medical Center. She is also working to get patients who have had deep brain stimulation to treat their Parkinson's involved with Giancardo's program. A typing profile could show how a person might benefit from deep brain stimulation, which implants a Mya Schiess, M.D., left, is working with Luca Giancardo, Ph.D., on "passive monitoring" of keystrokes to help diagnose Parkinson's disease. Whether you are drawing up plans to build your dream home, buying your first home, or currently own a home, Amegy Bank ® is a great place to start. Our experienced mortgage bankers are here to help guide you to the loan program* that fits your unique needs. Our programs include: • One Time Close Construction Loans • Portfolio Loans • Home Refinance Loans • Early Professional Programs At Amegy ® , we believe that strong client relationships are the foundation of successful mortgage experiences. Contact me today! JUMBO LOANS | CONSTRUCTION | PROFESSIONAL PROGRAMS Kathleen P. McTague 713.858.4678 kathleen.mctague@amegybank.com www.amegybank.com/kathleenmctague NMLS# 512526 *Loans subject to credit approval. Terms and conditions apply, amounts exceeding $424,100 qualify as jumbo loans, see mortgage banker for details. A division of ZB, N.A. Member FDIC, NMLS# 467014 Equal Housing Lender © 2017 ZB, N.A. 1717 West Loop South | Houston, Texas 77027

• Cover